Factors associated with glycemic variability in children with type 1 diabetes mellitus based on flash glucose monitoring system.
10.11817/j.issn.1672-7347.2022.210524
- Author:
Liyin ZHANG
1
;
Keyu GUO
2
;
Yaling XU
2
;
Jinlei BAI
3
;
Yujin MA
3
;
Liujun FU
3
;
Jie LIU
3
;
Keyan HU
3
;
Xia LI
2
;
Hongwei JIANG
4
;
Lin YANG
5
Author Information
1. Department of Endocrinology & Metabolism, Second Xiangya Hospital, Central South University, Changsha 410011. 198211060@csu.edu.cn.
2. Department of Endocrinology & Metabolism, Second Xiangya Hospital, Central South University, Changsha 410011.
3. Department of Endocrinology, First Affiliated Hospital of Henan University of Science and Technology, Luoyang Henan 471003, China.
4. Department of Endocrinology, First Affiliated Hospital of Henan University of Science and Technology, Luoyang Henan 471003, China. jianghw@haust.edu.cn.
5. Department of Endocrinology & Metabolism, Second Xiangya Hospital, Central South University, Changsha 410011. yanglin_nfm@csu.edu.cn.
- Publication Type:Journal Article
- Keywords:
flash glucose monitoring system;
glycemic variability;
type 1 diabetes mellitus
- MeSH:
Adolescent;
Blood Glucose;
Blood Glucose Self-Monitoring;
Child;
Diabetes Mellitus, Type 1/drug therapy*;
Glucose;
Glycated Hemoglobin A/analysis*;
Humans;
Hypoglycemia/prevention & control*;
Hypoglycemic Agents/therapeutic use*;
Insulin/therapeutic use*
- From:
Journal of Central South University(Medical Sciences)
2022;47(4):462-468
- CountryChina
- Language:English
-
Abstract:
OBJECTIVES:Patients with classical type 1 diabetes mellitus (T1DM) require lifelong dependence on exogenous insulin therapy due to pancreatic beta-cell destruction and absolute insulin deficiency. T1DM accounts for about 90% of children with diabetes in China, with a rapid increase in incidence and a younger-age trend. Epidemiological studies have shown that the overall glycated haemoglobin (HbA1c) and compliance rate are low in Chinese children with T1DM. Optimal glucose control is the key for diabetes treatment, and maintaining blood glucose within the target range can prevent or delay chronic vascular complications in patients with T1DM. Therefore, this study aims to investigate the glycemic control of children with T1DM from Hunan and Henan Province with flash glucose monitoring system (FGMS), and to explore factors associated with glycemic variability.
METHODS:A total of 215 children with T1DM under 14 years old were enrolled continuously in 16 hospitals from August 2017 to August 2020. All subjects wore a FGMS device to collect glucose data. Correlation of HbA1c, duration of diabetes, or glucose scan rates with glycemic variability was analyzed. Glucose variability was compared according to the duration of diabetes, HbA1c, glucose scan rates and insulin schema.
RESULTS:HbA1c and duration of diabetes were positively correlated with mean blood glucose, standard deviation of glucose, mean amplitude of glucose excursions (MAGE), and coefficient of variation (CV) of glucose (all P<0.01). The glucose scan rates during FGMS wearing was significantly positively correlated with time in range (TIR) (P=0.001) and negatively correlated with MAGE and mean duration of hypoglycemia (all P<0.01). Children with duration ≤1 year had lower time below range (TBR) and MAGE when compared with those with duration >1 year (all P<0.05). TIR and TBR in patients with HbA1c ≤7.5% were higher (TIR: 65% vs 45%, TBR: 5% vs 4%, P<0.05), MAGE was lower (7.0 mmol/L vs 9.4 mmol/L, P<0.001) than those in HbA1c >7.5% group. Compared to the multiple daily insulin injections group, TIR was higher (60% vs 52%, P=0.006), MAGE was lower (P=0.006) in the continuous subcutaneous insulin infusion group. HbA1c was lower in the high scan rates (≥14 times/d) group (7.4% vs 8.0%, P=0.046), TIR was significantly higher (58% vs 47%, P<0.001), and MAGE was lower (P<0.001) than those in the low scan rate (<14 times/d) group.
CONCLUSIONS:The overall glycemic control of T1DM patients under 14 years old in Hunan and Henan Province is under a high risk of hypoglycemia and great glycemic variability. Shorter duration of diabetes, targeted HbA1c, higher glucose scan rates, and CSII are associated with less glycemic variability.
